In vivo cisplatin resistance of rat ascites hepatoma AH66

Cancer Letters

Volumn 108, Issue 2, 1996, Pages 153-156

  Minamino, Tomoyoshi ^a   Nomura, Masaaki ^b   Tamai, Mitsuo ^c   Moritani, Shuzo ^d   Ohshima, Tohru ^a   Miyamoto, Ken Ichi ^b,c  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

^b HOKURIKU UNIVERSITY   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

^d FUKUI PREFECTURAL UNIVERSITY   (Japan)

Author keywords

AH66 cells; Ascites fluid; Cisplatin; In vivo resistance; Metallothionein; Rat ascites hepatoma

Indexed keywords

CISPLATIN; METALLOTHIONEIN; ZINC;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; ASCITES FLUID; ASCITES HEPATOMA; CULTURE MEDIUM; FETAL CALF SERUM; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; CISPLATIN; DRUG RESISTANCE, NEOPLASM; LIVER NEOPLASMS, EXPERIMENTAL; METALLOTHIONEIN; NEOPLASM PROTEINS; RATS; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0030606221     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(96)04385-6     Document Type: Article

References (16)

1. [1] Yoshida, T. (1956) Contributions of the ascites hepatoma to the concept of malignancy of cancer, Ann, N. Y. Acad. Sci., 63, 852-881.
2. [2] Miyamoto, K., Wakusawa, S. and Nakamura, S. (1992) Drug resistance dependent on different molecular size P-glycoproteins in Yoshida rat ascites hepatoma cells, Biochem. Pharmacol., 43, 1143-1145.
3. [3] Miyamoto, K., Wakusawa, S., Nakamura, S., Tajima, K. and Hidaka, H. (1992) Multidrug resistance in Yoshida rat ascites hepatoma cell lines, Anticancer Res., 12, 649-654.
4. [4] Wakusawa, S., Nakamura, S., Inoko, K. and Miyamoto, K. (1992) Sensitivity to antitumor drugs and vinblastine binding to membrane in rat ascites hepatoma AH66 cells, Chem. Pharm. Bull., 40, 2182-2184.
5. [5] Miyamoto, K., Wakabayashi, D., Minamino, T. and Nomura, M. (1994) Glutathione-S-transferase P-form dependent chlorambucil resistance in Yoshida rat ascites hepatoma cell lines, Cancer Lett., 78, 77-83.
6. [6] Hospers, G.A.P., Mulder, N.H., DeJong, B., DeLevy, L., Uges, D.R.A., Fichtinger-Schepman, A.M.J., Scheper, R.J. and DeVries, E.G.E. (1988) Characterization of a human small cell lung carcinoma cell line with acquired resistance to cis-diamminedichloroplatinum(II) in vivo, Cancer Res., 48, 6803-6807.
7. [7] Kelly, S.L., Basu, A., Teicher, B., Hacker, M.P., Harmer, D. and Laso, J.S. (1988) Overexpression of metallothioneins confers resistance to anticancer drugs, Science, 241, 1813-1815.
8. [8] Saburi, Y., Nagawa, M., Ono, M., Sakai, M., Muramatsu, M., Kohno, K. and Kuwano, M. (1989) Increased expression of glutathione S-transferase gene in cis-diamminedichloroplatinum(II)-resistant variants of Chinese hamster, Cancer Res., 49, 7020-7025.
9. [9] Teicher, B.A., Holden, S.A., Herman, S.T., Sotomayor, E.A., Kanderkar, V., Rosbe, K.W., Brann, T.W., Korbut, T.T. and Frei III, E. (1991) Characteristics of five human tumor cell lines and sublines resistant to cis-diamminedichloroplatinum(II), Int. J. Cancer, 47, 252-260.
10. [10] Kasahara, K., Fujiwara, Y., Nishio, K., Ohmori, T., Sugimoto, Y., Komiya, K., Matsuda, T. and Saijyo, N. (1991) Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin, Cancer Res., 51, 3237-3242.
11. [11] Miyamoto, K., Wakabayashi, D., Minamino, T., Nomura, M., Wakusawa, S. and Nakamura, S. (1996) Characterization of naturally acquired multiple-drug resistance of Yoshida rat ascites hepatoma AH66 cell line. Anticancer Res., in press.
12. [12] Onosaka, S., Tanaka, K., Doi, M. and Okahara, K. (1978) A simplified procedure for determination of metallothionein in animal tissue, Eisei Kagaku, 24, 128-131.
13. [13] Hamer, D.H. (1986) Metallothionein, Annu. Rev. Biochem., 55, 13-51.
14. [14] Wong, G.H W. and Goeddel, D.V. (1988) Tumor necrosis factor: modulation of synthesis and biological activities. In: Lymphocyte Activation and Differentiation, pp. 218-225. Edotors: J.C. Mani, and J. Conrad. de Gruyter, New York.
15. [15] Kondo, Y. and Kuo, S.M. (1994) Interleukin-1β-mediated metallothionein induction and cytoprotection against cadmium and cis-diamminedichloroplatinum, J. Pharmacol. Exp. Ther., 270, 1313-1318.
16. [16] Mizutani, Y., Bonavida, B., Koishihara, Y., Akamatsu, K., Ohsugi, Y. and Yoshida, O. (1995) Sensitization of human renal cell carcinoma cells to cis-diamminedichloroplatinum(II) by anti-interleukin 6 monoclonal antibody or anti-interleukin 6 receptor monoclonal antibody, Cancer Res., 55, 590-596.